Wipro GE Healthcare rolls out $1 billion expansion plan; confident of dodging impact of reciprocal US tariffs
Subscribe to enjoy similar stories. Wipro GE Healthcare, the 35-year-old joint venture between GE HealthCare and Wipro Enterprises, has started rolling out its $1 billion investment plan to expand manufacturing in India and boost exports, confident that it can dodge the impact of reciprocal tariffs that the US may impose on India’s medtech industry. The company expects to make about 70% of its products for the Indian market locally by 2030, a top executive said, compared with 40-45% currently.
“Our anticipation is that by the end of this period, we will reach somewhere in the vicinity of 70% locally procured, locally manufactured products to meet the Indian market requirement," Chaitanya Sarawate, managing director of Wipro GE Healthcare, told Mint in an interview. The company also wants to scale up exports out of India. Wipro GE Healthcare exports medical devices to about 70 countries, with the US as its largest market, followed by Europe.
“We fully anticipate more countries to be serviced from the manufacturing plants here in India. So our plans are quite ambitious," he said. US President Donald Trump has said reciprocal tariffs will be imposed on imports from India.
At the same time, the Indian government is said to be considering cutting import duties on medical devices, leaving domestic manufacturers worried. However, Wipro GE Healthcare does not anticipate any significant impact from these shifts. Its diversified supply chains and global businesses keep it relatively insulated from geopolitical uncertainties.
Read on livemint.com